10 Jul 2013
Roche has called a halt to development of dual PPAR diabetes candidate aleglitazar due to safety concerns.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024